Select Medical (SEM) Expected to Announce Quarterly Earnings on Thursday

Select Medical (NYSE:SEM) is expected to be posting its quarterly earnings results after the market closes on Thursday, February 20th. Analysts expect Select Medical to post earnings of $0.29 per share and revenue of $1.50 billion for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Select Medical Stock Performance

Shares of Select Medical stock opened at $18.58 on Tuesday. Select Medical has a 12 month low of $18.02 and a 12 month high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.41 billion, a PE ratio of 8.68, a price-to-earnings-growth ratio of 0.65 and a beta of 1.45. The business has a fifty day simple moving average of $19.16 and a 200-day simple moving average of $28.31.

Insider Buying and Selling at Select Medical

In other news, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. The trade was a 59.26 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on SEM shares. Royal Bank of Canada upped their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. UBS Group decreased their target price on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Finally, StockNews.com downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, February 13th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Select Medical presently has an average rating of “Hold” and a consensus target price of $39.50.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.